Skip to main content
. 2011 Jul;18(7):1067–1076. doi: 10.1128/CVI.05030-11

Fig. 3.

Fig. 3.

CD4 (A) and CD19 (B) cell proliferation assessed by BrdU incorporation. Fresh lymphoid PP, MLN, and spleen cells from mice orally primed with GK-1, BLS-GK-1, and BLS plus GK-1 and boosted with GK-1 or nonimmunized mice were costained with anti-BrdU (FITC), rat anti-mouse CD4 (PE), or rat anti-mouse CD19 (PE). The percentage of positive cells in each quadrant is shown. Data are representative of three independent experiments.